Kale has been cultivated since ancient Greek and Roman times, among the earliest cultivated forms of the Brassica oleracea species that also gave rise to cabbage, broccoli, and Brussels sprouts. It remained a staple vegetable across Europe for centuries, particularly valued for surviving cold winters, before experiencing a dramatic modern resurgence as a "superfood" starting in the 2010s.
Kale's exceptionally dense nutrient profile has driven real, if still preliminary, clinical research into its cardiovascular and metabolic effects.
Kale has real, positive human randomized controlled trial evidence for cholesterol management. A 12-week trial found men with high cholesterol who drank kale juice daily experienced a significant 27% increase in HDL cholesterol and a significant reduction in LDL and the atherogenic index — though the study's own authors recommended "longer clinical trials using a parallel design" to strengthen the findings. A separate 12-week RCT in type 2 diabetes patients found daily freeze-dried kale bars significantly reduced HbA1c, insulin resistance, and body weight compared to placebo.
Given real, positive individual RCTs for both cholesterol and diabetes markers — but genuinely small sample sizes and researchers' own honest calls for larger, more rigorously designed confirmatory studies — "Limited-Moderate" is the accurate, appropriately cautious rating.
Leaves cooked in soups and stews, or eaten raw in salads; increasingly juiced or dried into powder/bars for supplement use.